Eculizumab in pregnancy-associated atypical hemolytic uremic syndrome: insights for optimizing management

Journal of Nephrology

Volumn 28, Issue 5, 2015, Pages 641-645

  De Sousa Amorim, Erika ^a   Blasco, Miquel ^a   Quintana, Luis ^a   Sole, Manel ^a   de Cordoba, Santiago Rodríguez ^b   Campistol, Josep Maria ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

Eculizumab; Hemolytic uremic syndrome; Post partum; Pregnancy

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BENZATHINE PENICILLIN; BILIRUBIN; CREATININE; ECULIZUMAB; HEMOGLOBIN; LACTATE DEHYDROGENASE; MONOCLONAL ANTIBODY;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ASTHENIA; ATROPHY; CASE REPORT; CEPHALOPELVIC DISPROPORTION; CESAREAN SECTION; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; FEMALE; FIBROSIS; GENERALIZED EDEMA; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; RENAL REPLACEMENT THERAPY; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; ATYPICAL HEMOLYTIC UREMIC SYNDROME; BIOPSY; DISEASE MANAGEMENT; FOLLOW UP; KIDNEY; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS; REMISSION;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; ATYPICAL HEMOLYTIC UREMIC SYNDROME; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY; PREGNANCY; PREGNANCY COMPLICATIONS; REMISSION INDUCTION;

EID: 84941219993     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.1007/s40620-015-0173-5     Document Type: Article

References (16)

1. Dashe JS, Ramin SM, Cunningham FG (1998) The long-term consequences of thrombotic microangiopathy (thrombotic thrombocytopenic purpura and hemolytic uremic syndrome) in pregnancy. Obstet Gynecol 91:662–668
2. Fakhouri F, Roumenina L, Provot F et al (2010) Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. J Am Soc Nephrol 21:859–867
3. Faguer S, Huart A, Frémeaux-Bacchi V, Ribes D, Chauveau D (2013) Eculizumab and drug-induced haemolytic-uraemic syndrome. Clin Kidney J 6:484–485
4. Delmas Y, Bordes C, Loirat C, Frémeaux-Bacchi V, Combel C (2013) Post-partum atypical haemolytic-uraemic syndrome treated with eculizumab: terminal complement activity assessment in clinical practice. Clin Kidney J 6:243–244
5. Cañigral C, Moscardó F, Castro C et al (2014) Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome. Ann Hematol 93:1421–1422
6. Ardissino G, Wally OM, Maria BG, Rigotti A, Cugno M (2013) Eculizumab for atypical hemolytic uremic syndrome in pregnancy. Obstet Gynecol 122(2 Pt 2):487–489
7. Zschiedrich S, Prager EP, Kuehn EW (2013) Successful treatment of the postpartum atypical hemolytic uremic syndrome with eculizumab. Ann Intern Med 2(159):76
8. Kourouklaris A, Ioannou K, Athanasiou I et al (2014) Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report. J Med Case Rep 8:307
9. Robson JS, Martin AM, Ruckley VA, MacDonald MK (1968) Irreversible post partum renal failure. A new syndrome. QJ Med 37:423
10. Loirat C, Frémeaux-Bacchi V (2011) Atypical hemolytic uremic syndrome. Orphanet J Rare Dis. 6:60
11. Anacleto FE, Cifra CL, Elises JS (2003) Postpartum hemolytic uremic syndrome in a 17-year-old Filipina primigravid. Pediatr Nephrol 18:1283–1285
12. McMinn JR, George JN (2001) Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy. J Clin Apher. 16:202–209
13. George JN (2003) The association of pregnancy with thrombotic thrombocytopenic purpura–hemolytic uremic syndrome. Curr Opin Hematol 10:339–344
14. George JN (2000) How I treat patients with thrombotic thrombocytopenic purpura–hemolytic uremic syndrome. Blood 86:1223–1229
15. Bresin E, Rurali E, Caprioli J et al (2013) Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype. J Am Soc Nephrol 24:475–486
16. Ardissino G, Testa S, Possenti I et al (2014) Discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome: a report of 10 cases. Am J Kidney Dis 64:633–637